Suppr超能文献

长期降压治疗停药后饮食变化对高血压复发的影响(DISH)。高血压饮食干预研究。

Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension.

作者信息

Blaufox M D, Langford H G, Oberman A, Hawkins C M, Wassertheil-Smoller S W, Cutter G R

出版信息

J Hypertens Suppl. 1984 Dec;2(3):S179-81.

PMID:6599665
Abstract

The possibility exists that dietary modification may increase the number of patients who remain normotensive after drug withdrawal. In an effort to resolve this question, former Hypertension Detection and Follow-up Program Stepped Care participants (n = 496) were randomized into four major groups at the end of the programme (greater than 5 years antihypertensive therapy): controls (continue medication); discontinue medication, no dietary intervention; discontinue medication and weight loss; discontinue medication and reduce sodium. Groups 1, 2 and 4 were further divided into obese (greater than or equal to 120% ideal weight, and non-obese groups). The weight reduction group (greater than or equal to 120% ideal weight) lost 10.1 +/- 11 lbs without changing dietary sodium (n = 87). The sodium restriction group reduced urine sodium excretion from 145 to 97 mEq per day (n = 169). Sixty per cent of the weight loss group were normotensive at 56 weeks compared to 35% withdrawn from medication without dietary intervention. The highest 56 weeks success rates were in the mild non-overweight hypertensives on sodium restriction (78%), and the mild overweight hypertensives on weight reduction (72%). Randomization to either weight loss group or sodium restriction group increased the likelihood of remaining off drugs (adjusted odds ratio of 3.43 for the weight group and 2.17 for the sodium group (P less than 0.05). Age, severe hypertension greater than 5 years previous to entry into Dietary Intervention Study of Hypertension (DISH) or need for several drugs increased the chance of failure.

摘要

饮食调整有可能增加停药后仍保持血压正常的患者数量。为了解决这个问题,高血压检测与随访计划阶梯治疗的前参与者(n = 496)在该计划结束时(接受超过5年的抗高血压治疗)被随机分为四大组:对照组(继续用药);停药,无饮食干预;停药并减重;停药并减少钠摄入。第1、2和4组又进一步分为肥胖组(体重超过或等于理想体重的120%)和非肥胖组。减重组(体重超过或等于理想体重的120%)在未改变饮食钠摄入的情况下体重减轻了10.1±11磅(n = 87)。限钠组的尿钠排泄量从每天145毫当量降至97毫当量(n = 169)。56周时,减重组60%的患者血压正常,而未进行饮食干预就停药的患者中这一比例为35%。56周成功率最高的是轻度非超重高血压患者进行限钠治疗(78%),以及轻度超重高血压患者进行减重治疗(72%)。随机分配到减重组或限钠组会增加停药的可能性(减重组调整后的优势比为3.43,限钠组为2.17(P<0.05))。年龄、进入高血压饮食干预研究(DISH)前5年以上的重度高血压或需要多种药物治疗会增加失败的几率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验